Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/185584
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorMartín-Pardillos, Ana-
dc.contributor.authorValls Chiva, Ángeles-
dc.contributor.authorBande Vargas, Gemma-
dc.contributor.authorHurtado Blanco, Pablo-
dc.contributor.authorPiñeiro Cid, Roberto-
dc.contributor.authorGuijarro, Pedro J.-
dc.contributor.authorHümmer, Stefan-
dc.contributor.authorBejar Serrano, Eva-
dc.contributor.authorRodriguez-Casanova, Aitor-
dc.contributor.authorDíaz-Lagares, Ángel-
dc.contributor.authorCastellvi, Josep-
dc.contributor.authorMiravet-Verde, Samuel-
dc.contributor.authorSerrano, Luis-
dc.contributor.authorLluch-Senar, María-
dc.contributor.authorSebastián, Víctor-
dc.contributor.authorBribián, Ana-
dc.contributor.authorLópez-Mascaraque, Laura-
dc.contributor.authorLópez-López, Rafael-
dc.contributor.authorRamón y Cajal, Santiago-
dc.date.accessioned2019-07-07T03:48:56Z-
dc.date.available2019-07-07T03:48:56Z-
dc.date.issued2019-07-05-
dc.identifier.citationBMC Cancer 19(1): 666 (2019)-
dc.identifier.urihttp://hdl.handle.net/10261/185584-
dc.description.abstract[Background] Cancer is a rapidly evolving, multifactorial disease that accumulates numerous genetic and epigenetic alterations. This results in molecular and phenotypic heterogeneity within the tumor, the complexity of which is further amplified through specific interactions between cancer cells. We aimed to dissect the molecular mechanisms underlying the cooperation between different clones.-
dc.description.abstract[Methods] We produced clonal cell lines derived from the MDA-MB-231 breast cancer cell line, using the UbC-StarTrack system, which allowed tracking of multiple clones by color: GFP C3, mKO E10 and Sapphire D7. Characterization of these clones was performed by growth rate, cell metabolic activity, wound healing, invasion assays and genetic and epigenetic arrays. Tumorigenicity was tested by orthotopic and intravenous injections. Clonal cooperation was evaluated by medium complementation, co-culture and co-injection assays.-
dc.description.abstract[Results] Characterization of these clones in vitro revealed clear genetic and epigenetic differences that affected growth rate, cell metabolic activity, morphology and cytokine expression among cell lines. In vivo, all clonal cell lines were able to form tumors; however, injection of an equal mix of the different clones led to tumors with very few mKO E10 cells. Additionally, the mKO E10 clonal cell line showed a significant inability to form lung metastases. These results confirm that even in stable cell lines heterogeneity is present. In vitro, the complementation of growth medium with medium or exosomes from parental or clonal cell lines increased the growth rate of the other clones. Complementation assays, co-growth and co-injection of mKO E10 and GFP C3 clonal cell lines increased the efficiency of invasion and migration.-
dc.description.abstract[Conclusions] These findings support a model where interplay between clones confers aggressiveness, and which may allow identification of the factors involved in cellular communication that could play a role in clonal cooperation and thus represent new targets for preventing tumor progression.-
dc.description.sponsorshipSRYC acknowledges support from Fondo de Investigaciones Sanitarias (FIS; PI17/02247 and PI14/01320), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC; CB16/12/00363) and Generalitat de Catalunya (AGAUR; 2017 SGR 1799 and 2014 SGR 1131). AMP is funded by a FP7 Marie Sklodowska-Curie COFUND program under Grant Agreement n° 267128 (INCOMED program). ADL is funded by a “Juan Rodés” contract (JR17/00016) from ISCIII.-
dc.language.isoen-
dc.publisherBioMed Central-
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/267128-
dc.rightsopenAccess-
dc.subjectTumor-
dc.subjectBreast-
dc.subjectCancer-
dc.subjectMetastasis-
dc.subjectHeterogeneity-
dc.subjectClone-
dc.subjectCommunication-
dc.subjectCooperation-
dc.subjectMDA-MB-231-
dc.titleThe role of clonal communication and heterogeneity in breast cancer-
dc.typeartículo-
dc.identifier.doi10.1186/s12885-019-5883-y-
dc.description.peerreviewedPeer reviewed-
dc.relation.publisherversionhttps://doi.org/10.1186/s12885-019-5883-y-
dc.relation.publisherversionPublisher's version-
dc.identifier.e-issn1471-2407-
dc.date.updated2019-07-07T03:48:56Z-
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0/-
dc.contributor.funderGeneralitat de Catalunya-
dc.contributor.funderInstituto de Salud Carlos III-
dc.contributor.funderEuropean Commission-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100002809es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.pmid31277602-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.openairetypeartículo-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.languageiso639-1en-
Aparece en las colecciones: (IC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
role_clonal_communication_heterogeneity_breast_cancer.pdf11,35 MBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

26
checked on 09-abr-2024

SCOPUSTM   
Citations

34
checked on 16-abr-2024

WEB OF SCIENCETM
Citations

33
checked on 23-feb-2024

Page view(s)

343
checked on 19-abr-2024

Download(s)

183
checked on 19-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons